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Abstract The International Workshop on the Molecular
Biology of the Stress Response organized by the Cell Stress
Society International was held in Porto Alegre, Brazil, on
May 27–30, 2012, as part of the development of the Latin
American Chapter of the Society, a superb initiative headed
by Drs. Antonio De Maio and Larry Hightower. The meet-
ing took place in the wonderful facilities of the Pontifícia
Universidade do Rio Grande do Sul (PUCRS) and was
warmly chaired by Professor Cristina Bonorino. Thirty-
four invited speakers presented their work to more than
200 scientists and, even more importantly, to 150 registered
students, who were the main beneficiaries of the meeting.
The first day of the workshop was dedicated to an educa-
tional program for students, young investigators, and partic-
ipants who were unfamiliar with the field of molecular
chaperones and the stress response. Speakers in this pre-
workshop were Dr. Harm Kampinga, Dr. Lea Sistonen, Dr.
Larry Hightower, Dr. Ivor Benjamin, Dr. Daniel Ciocca, and
Dr. Linda Hendershot. Then, the scientific sessions discussed
below followed.
Introduction
The most common types of stress are physical (temperature,
exhausting activities, loud noise, radiation, etc.) or chemical
(oxidative or reductive environments, poisons, toxins, etc.),
but they can also be psychological stemming, for example,
from feelings of anxiety, remorse or sadness. Everyone
copes with stress in different ways, but it is an unavoidable
fact of everyday life for us all. The meeting, however, was
an exception to this rule. It gave us the opportunity to
discuss new developments in a relaxed and friendly atmo-
sphere where stress only occurred in the titles of the talks.
The heat shock proteins (HSPs) of every participant were
expressed only at a very basal level. We were indebted to the
local organizers for such a pleasant and friendly
environment.
Speakers described the latest work in the chaperone field
and the regulation of the stress response (see the meeting
blog site at http://workshopcellstress2012.blogspot.com/),
and the topics of each session were primarily selected
according to their relevance to cellular stress response re-
search by South American groups.
Stress responses in the nervous system
Vilma Martins (Hospital AC Camargo, São Paulo, Brazil)
opened this session with a report on how astrocytes secrete a
population of microvesicles of different size and morpholo-
gy that not only contain classical exosomal markers but also
stress-inducible protein 1, a co-chaperone that lacks peptide
signals to be secreted and leads to neurotrophic and neuro-
protective actions upon binding to the prion protein PrPC at
the neuronal surface.
María Soledad Matus (Universidad de Chile, Santiago,
Chile) discussed the complex network of protein misfolding
stresses generated in the most common neurodegenerative
diseases such as Parkinson’s disease, Alzheimer’s disease,
amyotrophic lateral sclerosis, and Huntington’s disease and
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how cells activate the unfolded protein response, assessing
the role of endoplasmic reticulum stress in these disorders.
The roles of some factors such as SOD1, BP1, and ATF4
were discussed as possible targets of therapeutic strategies.
Ian R. Brown (University of Toronto, Canada) examined
the role of Hsp70B (HSPA6) in differentiated human neu-
ronal cells. Following heat shock, this stress-inducible chap-
erone was detected concentrated at centrosomes and then at
foci in the nucleus that are associated with active transcrip-
tion sites and RNA splicing, perhaps as a protective mech-
anism. Celastrol, a traditional compound used in traditional
Chinese medicine, induces the expression of Hsp70B, sug-
gesting that this triterpene could be useful as a neuroprotec-
tive drug.
María Estela Andrés (Pontificia Universidad Católica de
Chile, Santiago, Chile) showed that particular epigenetic
mechanisms could regulate Hsp70 expression in rat cortical
neurons and PC12 cell models. While HSF1 is induced and
translocated to the nucleus during the onset of heat shock, it
does not bind to DNA. The chromatin environment on the
Hsp70 gene promoter does not show features of heterochro-
matin, and a significant increase of H3 acetylation is not
enough to induce Hsp70 expression. Also, the repressed
state of Hsp70 expression in neurons is not related to the
LSD1-CoREST repressor complex regulation. Therefore, it
was suggested that another fine-tuned dialog between his-
tone postranslation modifications and chromatin architec-
ture could be responsible for triggering Hsp70 gene
transcription in neurons.
Hugo Peluffo (Instituto Pasteur de Montevideo, Montive-
deo, Uruguay) presented studies on the regulation of neu-
ronal survival by the CD300f immunoreceptor in the normal
and injured brain. This receptor (normally expressed in
monocytes and neutrophiles) has recently been described
in neurons and is up-regulated after brain injury, particularly
in the white matter. The ligand appears to be produced by
glial cells, and its nature is still poorly understood. In view
of these novel findings, it is postulated that the overexpres-
sion of CD300f may represent a feasible gene therapy
strategy.
Transcription factors in heat shock responses
Maria Gabriella Santoro (Università di Roma Tor Vergata,
Rome, Italy) gave a full overview of the complex functional
interplay between HSF1 activation and inflammatory sig-
naling factors, important components of the tumor microen-
vironment. HSF1 was recently hypothesized to regulate the
expression of non-HSP genes in a non-canonical and poorly
understood manner. The talk integrated the pathways of
some of these players, which seem to be connected to
HSF1 function. NFkB is inhibited by HSF1 upon the onset
of heat shock increasing apoptosis of B cell malignancies
and myelomas, where NFkB appears to be constitutively
active. Also discussed was arsenite-inducible RNA-
associated protein, the heat shock gene whose expression
is temperature-dependent and strictly controlled by HSF1.
Moreover, it was shown that heat stress promotes the ex-
pression of cyclooxygenase-2, a key regulator of inflamma-
tion controlling prostanoids and thromboxane synthesis.
Lea Sistonen (Åbo Akademi University, Turku, Finland)
focused her talk on the interplay between HSF1 and HSF2
in both cell stress and developmental processes. In view of
the newly expanded repertoire of HSF targets well beyond
chaperone-encoding genes, a genome-wide mapping of the
target sites of HSF1 and HSF2 was performed in human
K562 erythroleukemia cells that are either freely cycling or
arrested in mitosis. A comparison of the target loci occupied
by either HSF1 or HSF2 reveals a clearly distinct set of
targets in cells under normal growth conditions. Upon ex-
posure to heat stress, the number of targets increases re-
markably, and HSF1 and HSF2 share a majority of their
targets and recognize identical cis-acting DNA sequences.
Therefore, a number of post-translational modifications of
HSF1 were analyzed. Phosphorylation and sumoylation of
HSF1 occur rapidly on heat shock, whereas the kinetics of
acetylation (where deacetylase SIRT1 plays a pivotal role)
are delayed and coincide with the attenuation phase of the
HSF1 activation cycle.
Ayesha Murshid (Harvard Medical School, Boston, USA)
reported on the mechanisms of HSF1 regulation that may
become compromised with age and found that HSF1 binds
to the catalytic domain of protein kinase A (PKAcα) and
becomes phosphorylated. It was shown that PKA triggers a
cascade involving HSF1 binding to p300 and p-TEFb and
phosphorylation of the C-terminal domain of RNA poly-
merase II. It was suggested that this cascade appears to play
a key role in protein quality control in neuronal cells
expressing aggregation-prone proteins with long poly-
glutamine (poly-Q) tracts since they form inclusion bodies
that could be resolved by HSF1 activation during heat
shock.
Stress proteins and microbiology
Steve Witkin (Weill Cornell Medical College, NY, USA)
underlined the role for HSPs in various aspects of women’s
health, in particular as biomarkers for the development of
recurrent vulvo-vaginal infections, recurrent miscarriages,
and genital malignancies. Dr. Witkin showed the importance
of early detection of IgM antibodies against Hsp70 as a
potential marker for CMV infections.
Lara Linhares (Universidade de São Paulo, São Paulo,
Brazil) discussed the relevance of screening tests for the
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detection of Chlamydia trachomatis infections. Chronic ex-
posure to chlamydial Hsp60 can lead to induction of an
immune response against conserved epitopes that are also
present in human Hsp60. Since Hsp60 is one of the first
proteins expressed by the human embryo, these antibodies
and activated T lymphocytes that recognize the human
Hsp60 increase the likelihood of inflammation-related preg-
nancy failure.
Manuel A. Barbieri (Florida International University,
Miami, USA) presented data showing how exotoxin-S from
Pseudomonas aeruginosa directly affects the activation of one
or more Rab5-specific guanine nucleotide exchange factors in
macrophages by down-regulation during bacteria invasion
and how Rin-1 reverses such inactivation of Rab5.
Wolfgang Schumann (University of Bayreuth, Bayreuth,
Germany) talked about the role of the Bacillus subtilis FtsH
metalloprotease during initiation of sporulation. This ATP-
and Zn2+-dependent protease is required for the initiation of
sporulation, which results in the production of phosphory-
lated Spo0A, a master regulator to allow cells to enter the
second phase. FtsH controls the amount of negative regu-
lators of active Spo0A, the phosphatase Spo0E able to
specifically dephosphorylate phospho-Spo0A being identi-
fied as one of these regulators.
Oxidative and nitrosative stress
Ivor Benjamin (University of Utah, Salt Lake City, USA)
provided a comprehensive overview of the importance of a
balanced redox state in the response pathways, particularly
in cardiomyocytes where differences among their organelles
are more notorious than in other cell types due to the highly
oxidative metabolism of their mitochondria. He showed
how CryAB (HSPB5) mutants recapitulate human cardiop-
athies by generating redox imbalance and protein misfold-
ing and aggregation. Since only half of these specialized
cells are replaced during the human life span, strategies for
maintenance of these cells relies on uninterrupted renewal of
their components, among them, key transient interactions of
cardiac proteins with molecular chaperones.
Claudina Rodrigues-Pousada (Instituto de Tecnologia
Química e Biológica, Universidade Nova de Lisboa, Portu-
gal) presented studies on the genome-wide response of
Saccharomyces cerevisiae exposed to arsenic. Her data
showed that the transcription factor Yap1 (Yeast AP-1 like)
is responsible for maintaining cellular redox homeostasis and
regulates the expression of genes involved in the Fe-S protein
biosynthesis. Among them, Fet3, a ferroxidase required for
high-affinity iron uptake, is drastically decreased, whereas fet3
mutants show arsenate resistance, suggesting that Fet3 plays a
role in arsenic toxicity. Unexpectedly, arsenic treatment acti-
vates non-reductive iron uptake systems. It was shown that
this arsenic disruption of iron homeostasis also occurs in
mammalian cells, which could be relevant to clinical
applications.
Magnus Ake Gidlund (Faculdade de Medicina, Pontifícia
Universidade Católica, Porto Alegre, Brazil) discussed the
oxidative stress response and atherosclerosis generation re-
lationship, and the different ways of evaluating the damage
that leads to increased oxidized lipoproteins. Since antibod-
ies against oxidized lipoproteins are produced, it was pro-
posed that in adults without atherosclerotic disease, the
metabolic regulation and carotid atherosclerosis of oxidized
LDL antibodies and oxidized LDL groups characterize a
dual attribute in the former as a contributor to carotid ath-
erosclerosis (less than oxidized LDL), and with a modest
atheroprotective role.
Norma Possa Marroni (Universidade Federal do Rio
Grande do Sul-HCPA, Porto Alegre, Brazil), analyzed the
effects of glutamine treatment on oxidative/nitrosative stress
and VEGF-Akt-eNOS signaling pathway in a portal hyper-
tension model. It was shown that glutamine can be useful in
reducing oxidative/nitrosative damage. While the treatment
could have a beneficial role, it does not reduce angiogenesis
by stimulating the overproduction of VEGF.
Chaperones
Harm Kampinga (Department of Cell Biology, SSCB, Gro-
ningen, The Netherlands) showed data on the role of mo-
lecular chaperones as possible therapeutic targets in the
routing of misfolded and aggregated proteins in neurode-
generative diseases. DNAJB6 and DNAJB8 form large olig-
omeric complexes able to prevent aggregation in a manner
that depends on regulation by HDAC4. Unlike canonical
DNAJ proteins such as DNAJB1, those DNAJ proteins do
not assist HSP70 but bind small peptides and can prevent
“aggregate seeding” of thermally denatured proteins. Trans-
genic mice with brain-specific overexpression of the human
DNAJB6 were tested for their susceptibility to poly-Q me-
diated neurodegeneration, and data suggest that this DNAJ
protein prevents poly-Q aggregation, toxicity, and, poten-
tially, neurodegeneration.
Carlos Ramos (Instituto de Química, UNICAMP, Campi-
nas, Brazil) presented studies on the structure–function re-
lationship of molecular chaperones by using biophysical
tools. In spite of the fact that the function of a protein is
directly dependent on its three-dimensional structure, high-
resolution information is not always available and is diffi-
cult to obtain for proteins with high molecular mass or high
oligomerization state, as is the case with chaperones. Studies
on the quaternary structure of several chaperones were dis-
cussed, highlighting those on the orientation of the J-domain
in Hsp40s, the relationship between oligomerization and
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function in small Hsps and on the characterization of Hsp90
and Hsp100 in plants.
Linda Hendershot (St. Jude Children’s Research Hospi-
tal, Memphis, USA) discussed her work on chaperones of
the endoplasmic reticulum. It is not known how the ER can
distinguish between proteins that have not yet folded and
those that cannot fold. Recent data suggest that molecular
chaperones might be able to participate in both protein
folding and degradation through the association of distinct
subsets of co-chaperones. In addition, the finding that fold-
ing and degradation might be spatially separated in the ER
provides a possible mechanism for establishing different
environments to allow these opposing functions to exist
within a single organelle.
Mariana Borsa (Centro de Ciências Biológicas, Univer-
sidade Federal de Santa Catarina, Florianópolis, Brazil)
summarized studies on ATF6, one of the three sensors of ER
for stress (along with PERK and IRE1) in HIV-infected
patients. That protein leaves the endoplasmic reticulum
when it is activated and transits to the Golgi complex where
it suffers proteolytic cleavage. Its 50-kDa domain acts as
transcription factor when it is free in the cytoplasm and
induces the expression of chaperones. The study showed
how the HIV promotes UPR activation through the ATF6
pathway in cells from HIV-positive patients undergoing
different antiretroviral therapies.
Vince Guerreiro (University of Arizona, Tucson, USA)
provided evidence that HspBP1, an Hsp70 co-chaperone
identified by this laboratory, has activity both inside and
outside the cell. HspBP1 binds to the ATPase domain of
Hsp70, which results in the removal of bound nucleotides
and prevents the protein refolding activity of Hsp70. The N-
terminal region of 39–44 amino acids is not present in other
vertebrates and is the region required for inhibition of
refolding activity. Overexpression of HspBP1 inhibits tumor
growth and is also detected in serum. Interestingly, tumor
growth was inhibited following i.v. injection of HspBP1.
Mario Galigniana (Universidad de Buenos Aires-Instituto
de Biología y Medicina Experimental, Buenos Aires, Argen-
tina) presented a novel model where the expression balance
of FKBP51 and FKBP52, two Hsp90-binding immuno-
philins, regulate several basic process of the cell. While
FKBP51 is associated with unliganded steroid receptor-
Hsp90 complexes and released upon binding of the hor-
mone, FKBP52 occupies the same binding site on Hsp90
and interacts with the dynein motor protein, which favors
the transport of the receptor to the nucleus. FKBP52 (but
not FKBP51) interacts with structures of the nuclear pore
facilitating nuclear translocation of the cargo. Contrary to
previous conclusions, data showed that receptor transfor-
mation (i.e., Hsp90 dissociation) is not cytoplasmic but is
a nuclear event. At the transcriptional level, while
FKBP51 is a negative regulator, FKBP52 shows as a
positive factor. Similar observations were performed for
NFkB in cells stimulated with phorbol esters, although
the effects of the immunophilins are Hsp90-independent.
FKBP52 is also a protein related to neurodifferentiation,
a property counteracted by FKBP51. Currently, drugs are
being developed and tested to regulate selectively the
biological action of factors associated with these two
immunophilins.
Maristela Camargo (Universidade de São Paulo, São
Paulo, Brazil) presented work on the dysfunctional unfold-
ed protein response as a cause of hypogammaglobulinemia.
B cells from a patient suffering common variable immuno-
deficiency (CVI) do not have typical membrane-bound IgM.
Unfolded IgM chains co-localized with chaperone BiP in-
side the ER, and treatment of these cells in vitro with
chemical chaperones restored folding/secretion of IgM.
Some of these patients had a decreased number of mature
B cells and an increased number of immature B cells that in
earlier stages were normally restricted to lymphoid tissues.
One of these patients presented chronic ER stress, suggest-
ing an inability to deal with physiological demands for
protein folding.
Fernanda Sodré (Universidade de São Paulo, São Paulo,
Brazil), a student from Dr. Camargo’s group, presented a
complementary study attempting to identify gene mutations
that could explain the defective activation found in CVI
patients and how these mutations impair the ability to fold
and secrete immunoglobulins. About 90 non-conservative
substitutions of amino acids or gaps on the BiP sequence of
these patients were found. All of them were able to disrupt
BiP chaperone folding activity, which may explain the ac-
cumulation of immunoglobulins in the ER, and ultimately,
the hypogammaglobulinemia exhibited by these patients.
HSP and cancer
Daniel Ciocca (Instituto de Medicina y Biología Experimen-
tal de Cuyo,Mendoza, Argentina) discussed the interrelation
between caveolin-1 and heat shock proteins in cancer. Tis-
sue sections of stromal and tumor epithelial cells were
analyzed from two cohorts of breast cancer patients. It was
found that the expression of caveolin-1 in the tumor micro-
environment rather than in the tumor epithelial compartment
correlates with the clinical outcome. This observation was
also supported by studies of Her2/Neu-driven tumor devel-
opment in caveolin-1 null mice, where tumor onset is accel-
erated in the absence of stromal caveolin. On the other hand,
it was analyzed how caveolin-1 interacts with β-catenin,
HSPB1 (Hsp27/Hsp25), and HSPA/Hsp70, and the regula-
tion of caveolae endocytosis by the actin cytoskeleton, and
how HSPB1 regulates actin polymerization. It was finally
suggested that stromal caveolin-1 could be a new prognostic
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marker for breast cancer progression and that the disruption
of its gene may cause alterations of specific Hsps favoring
tumor development.
Daiana Alvarez-Olmedo (Instituto de Medicina y Biolo-
gía Experimental de Cuyo, Mendoza, Argentina), a student
from Dr. Ciocca’s group, completed the previous picture by
evaluating the effects of a class 1 carcinogen such as cad-
mium on the expression and localization of β-catenin,
Hsp27, and caveolin-1 in ERα-positive and -negative cancer
cells lines. In MCF-7 cells, β-catenin localization was mod-
ified from membrane to the perinuclear region. Caveolin-1
changed from a cytoplasmic distribution to a paranuclear
location, and Hsp27 was observed in the cytoplasm with
noticeable dots in the nuclei.
Gisela Castro (Instituto de Medicina y Biología Experi-
mental de Cuyo,Mendoza, Argentina), another student from
Daniel Ciocca’s group, studied the differential expression of
HSPs in different subtypes of gliomas and their histopatho-
logic features, and correlated this with the molecular marker
LOH. It was demonstrated that in oligodendroglial tumors,
Hsp27 could be used as a surrogate marker of the conven-
tional prognosis marker LOH.
Pramod Srivastava (University of Connecticut Health
Center, Farmington, USA) reported that dendritic cells se-
quester antigenic epitopes in an immunologically active
form for weeks after the initial encounter with the antigen
and long after the intact antigen is degraded beyond detec-
tion. This was demonstrated in vitro and in vivo and appears
to be mediated through the interaction of the antigen with
Hsp90 during the initial uptake of antigen. It was proposed
that the ability of dendritic cells to store antigenic epitopes
as a part of a stress-inducible system may be advantageous
for immune responses to viruses and cancers.
María Bausero (Instituto de Investigaciones Biológicas
Clemente Estable, Montevideo, Uruguay) proposed the us-
age of nanotechnology approaches for silencing HSPs relat-
ed to tumor development. Hsp25/Hsp27 silencing by siRNA
or lentivirus-iRNA technology abrogated the metastatic po-
tential and induced the regression of established breast tumors.
On the other hand, silencing of the Hsp27 gene led to induc-
tion of caspase-3/7-dependent apoptosis and inhibition of cell
growth in vitro. Since delivery of siRNAs is difficult to
achieve; it was proposed to use nano-polymers of polyamido-
amine (PAMAM) for the treatment of solid tumors in a murine
breast cancer model. Since PAMAM dendrimers are good
carriers of hydrophobic drugs, they will be able to enhance
their solubility and consequently, their bioavailability.
Mathias Gehrmann (Technische Universitaet Muenchen,
Muenchen, Germany) discussed the lipid association of
membrane-bound Hsp70 and its implications on tumor ther-
apy. Hsp70 expression has been shown induced in many
tumor cells and primary tumors, such that Hsp70 could be a
good diagnostic and prognostic marker for tumors. In this
study, an association of membrane-expressed Hsp70 with
the tumor-specific lipid raft component globotriaosylcera-
mide, as well as with phosphatidylserine, which is found on
the outer membrane leaflet following stress was reported.
José Alexandre Barbuto (Instituto de Ciências Biomédicas-
Universidade de São Paulo, Brazil) addressed the interrelation
of HSPs and dendritic cell maturation in cancer patients. Al-
though responses to stress are orchestrated in a highly sensitive
manner by dendritic cells (DCs), tumors are not detected as a
potential danger and the immune response is not triggered.
Monocytes from cancer patients were studied and showed a
distinct pattern of activation, including a different pattern of
suppressors of cytokine signaling, before any differentiation
signal is delivered to them. Upon differentiation, the ensuing
DCs show increased levels of Hsp27 mRNA, but not intracel-
lular Hsp27 protein, indicating that cell stress upon monocytes
and DCs has a complex response pattern that needs to be better
characterized in cancer patients.
HSPs and immune tolerance
Willem van Eden (Utrecht University, Utrecht, The Nether-
lands) reported that T cell epitopes of Hsp70 can be targets
for epitope-specific immunotherapy in inflammatory diseases
via the activation of antigen-specific regulatory T cells. Nasal
application of a cross-reactive T cell epitope (B29) of Myco-
bacterium tuberculosis Hsp70 in mice suppressed
proteoglycan-induced arthritis. Treatment with the peptide,
both nasally and parenterally activated a potent CD4+CD25+
regulatory T cell population that reduced arthritis, showing
that antigen-specific Treg function in vivo can be enhanced
after immunization with antigens associated with inflamma-
tion. It was proposed that these peptides could be used to
amplify the naturally existing Hsp-specific regulatory T cell
response in patients with chronic inflammatory diseases.
Verónica Coelho (Faculdade de Medicina da Universi-
dade de São Paulo, São Paulo, Brazil) described strategies
to identify immunoregulatory Hsp60 peptides. Hsp60 is a
homeostatic molecule involved in the fine-tuning of inflam-
mation. It also shows a potential risk of triggering patholog-
ical autoimmunity. Therefore, it is necessary to develop
strategies to select Hsp60 peptides bearing predominantly
regulatory or inflammatory properties. To facilitate the se-
lection of the most promising combination of peptides, the
proposed strategies involve the analysis of the functional
immunologic profile of peptides by studying their interac-
tions with a panel of different cell types, the evaluation of
electrostatic properties of peptides, the study of interactions
with receptors, and the creation of a platform able to inte-
grate structural and functional data from the literature.
Kamal Moudgil (University of Maryland School of Med-
icine, Baltimore, USA) presented work on the modulation of
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autoimmunity by cytokine responses and immune tolerance
against Hsp65. Using an experimental model of rheumatoid
arthritis, the qualitative and quantitative aspects of the im-
mune response to Hsp60 was studied in rats that possess the
same MHC haplotype but display differential susceptibility
to adjuvant arthritis. The temporal kinetics of cytokine se-
cretion and the resulting balance contribute significantly to
disease susceptibility. IL-27 and interferon-γ regulate the
arthritic disease process by inhibition of the IL-17 response.
It was shown that a variety of compounds induce protection
via down-modulation of the IL-17 response to HSP60.
In the spirit of the workshop where students played a
major role, the last two talks were given by PhD students.
Like the others previously summarized here, the subjects
were selected from the submitted abstracts.
Thiago Borges (Pontifícia Universidade Católica do Rio
Grande do Sul, Porto Alegre, Brazil), from Dr. Cristina
Bonorino’s group, analyzedmechanisms of inhibition of acute
rejection induced by mycobacterial Hsp70 (TBHsp70). He
investigated the role of TLR2 and downstream signaling path-
ways involved in the effect of IL-10 production by bone
marrow dendritic cells stimulated with TBHsp70. TLR2 ex-
pression remained critical in the allograft, but not in the
recipient, for the inhibition of acute graft rejection induced
by TBHsp70. This process was dependent on MyD88 and IL-
10 expression in the allograft. The results presented here also
led to the conclusion that a maximal IL-10 production by the
cells stimulated with TBHsp70 is dependent on TLR2 and
ERK and independent of p38.
Ana Cristina Gomes-Santos (Universidade Federal de
Minas Gerais, Belo Horizonte, Brazil), from Ana M. Faria’s
group, investigated the effects of Hsp65-secreting Lactococ-
cus lactis in intestinal inflammatory disease models and
characterized the immunological mechanisms involved in
such intervention. It was shown that Hsp65 delivered by
Lactococcus lactis prevented intestinal inflammation via IL-
10 and TLR2 pathways. It was proposed that this type of
approach may lead to long-term management of inflamma-
tory bowel disease in genetically susceptible hosts.
Poster sessions
The well-attended poster sessions took place in the main hall
of the PUCRS facility. A total of 83 posters were discussed
dealing with the different aspects of the workshop.
Concluding remarks
This 9th International Workshop on the Molecular Biology
of Stress Responses provided an overview of the latest work
in the molecular biology of chaperones covering many
aspects of the field. We particularly hope that it also opened
new opportunities for young new researchers entering this
exciting field.
Today, we still recall the original discovery by Prof.
Ferrucio Ritossa, thanks to the combined effects of good
fortune, a great sense of inquisitiveness, and above all,
knowledge and vision to understand a phenomenon that
many people would let inadvertently pass. It is 50 years
since the publication of his pioneer observation that cells
exposed to high temperature can mount high transcriptional
activity for specific proteins, when the term heat shock
response was coined. We recall too that Prof. Ritossa expe-
rienced many setbacks before publishing his amazing dis-
covery because, according to the editor of a major journal
who first rejected his manuscript, “the studies lacked bio-
logical importance.” Fifty years later, the incredible over-
view of the field given during this meeting demonstrated
who was right and who was not.
Nonetheless, while significant progress has been made in
unraveling the molecular mechanisms governing the activity
of major chaperones in protein folding, a number of impor-
tant questions still remain to be answered. Among many
others are questions about the still unknown natural sub-
strates for many chaperones and about how different types
of heat shock proteins cooperate in a given biological sys-
tem. For those of us who are working in the field, this is a
challenge to be solved; it also makes more likely that we
will keep our jobs for a long time (fortunately).
The first CSSI workshop was organized in 1997 by
Professors S.C. Lakhotia (Varanasi, India) and W. Schumann
(Bayreuth, Germany) at The Banaras University, Varanasi,
India. The idea behind that initial workshop was to bring
state-of-the-art research to investigators who would nor-
mally miss out on participating in international meetings
because of a lack of resources. In this regard, the following
paragraph is reproduced from the meeting report written by
Dr. Peter Csermely and Dr. Subhash Lakhotia (Cell Stress
Chaperones (1998) 3:1–5): “Our proposal suggests the
sponsorship of stress-related conferences not in Europe
or in USA/Canada as a vehicle to propagate the newest
results of stress research to the interested scientific commu-
nity of the developing countries.” In view of the advances
achieved since then and the current proposal to develop a
Latin American Chapter of the Society, it can be said that
the original goals have been successfully achieved mainly
because of the high participation of investigators from devel-
oping countries at all nine workshops. Secondly, a high num-
ber of collaborations have come about as a result of these
workshops, and third, an important decision for the future of
the cellular stress response field in South America was taken
during a luncheon meeting chaired by Professor Antonio De
Maio. Attendees from various South American countries vot-
ed for the creation of the South American Chapter of the CSSI.
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Its organizing committee will consist of one member
from each of the participating countries, and Dr. María
Bausero from Uruguay was elected as first chairperson.
Accordingly, it was unanimously agreed that the next South
American Chapter Meeting will be held in Montevideo,
Uruguay, in 2014. Given the tremendous speed of re-
search in the chaperone field, it is expected that many
of the still unanswered questions described above will be
solved by that time. We all wish the best to María and will
support her in this new and challenging endeavor.
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